메뉴 건너뛰기




Volumn 34, Issue 3, 2008, Pages 198-201

Is it ethical to keep interim findings of randomised controlled trials confidential?

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENTIALITY; ETHICS; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; PERSONAL AUTONOMY; RANDOMIZED CONTROLLED TRIAL; RECUMBENCY; RESEARCH SUBJECT; UNITED STATES;

EID: 40649084135     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2006.019109     Document Type: Article
Times cited : (8)

References (10)
  • 1
    • 0037108141 scopus 로고    scopus 로고
    • Monitoring clinical trials: Issues and controversies regarding confidentiality
    • Fleming TR, Ellenberg S, DeMets DL. Monitoring clinical trials: issues and controversies regarding confidentiality. Statistics in Medicine 2002;21:2843-51.
    • (2002) Statistics in Medicine , vol.21 , pp. 2843-2851
    • Fleming, T.R.1    Ellenberg, S.2    DeMets, D.L.3
  • 2
    • 1542316128 scopus 로고    scopus 로고
    • Data safety and monitoring boards
    • Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med 2004;350:1143-7.
    • (2004) N Engl J Med , vol.350 , pp. 1143-1147
    • Slutsky, A.S.1    Lavery, J.V.2
  • 3
    • 0026660156 scopus 로고
    • When to stop a clinical trial
    • Pocock SJ. When to stop a clinical trial. BMJ 1992; 305:235-40.
    • (1992) BMJ , vol.305 , pp. 235-240
    • Pocock, S.J.1
  • 4
    • 0033993316 scopus 로고    scopus 로고
    • Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees
    • Wells RJ, Gartside PS, McHenry CL. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees. IRB 2000:22:7-11.
    • (2000) IRB , vol.22 , pp. 7-11
    • Wells, R.J.1    Gartside, P.S.2    McHenry, C.L.3
  • 5
    • 0035949071 scopus 로고    scopus 로고
    • Monitoring clinical trials - interim data should be publicly available
    • Lifford RJ, Braunholtz D, Edwards S, et al. Monitoring clinical trials - interim data should be publicly available. BMJ 2001;323:441-2.
    • (2001) BMJ , vol.323 , pp. 441-442
    • Lifford, R.J.1    Braunholtz, D.2    Edwards, S.3
  • 7
    • 0029283812 scopus 로고
    • Community-equipoise and the ethics of randomized clinical trials
    • Gifford F. Community-equipoise and the ethics of randomized clinical trials. Bioethics 1995;9:126-48.
    • (1995) Bioethics , vol.9 , pp. 126-148
    • Gifford, F.1
  • 8
    • 19344371548 scopus 로고    scopus 로고
    • The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program
    • Pocock S, Wang D, Wilhelmsen L, et al. The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2005:149:939-43.
    • (2005) Am Heart J , vol.149 , pp. 939-943
    • Pocock, S.1    Wang, D.2    Wilhelmsen, L.3
  • 9
    • 0023413293 scopus 로고
    • Policies for study monitoring and interim reporting of results
    • Green SJ, Fleming TR, O'Fallon JR. Policies for study monitoring and interim reporting of results. J Clin Oncology 1987; 5:1477-84.
    • (1987) J Clin Oncology , vol.5 , pp. 1477-1484
    • Green, S.J.1    Fleming, T.R.2    O'Fallon, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.